July 6, 2020 -- Investorshub NewsWire -- via Microcap Daily -- BY JACOB WATSON -- Alternet Systems, Inc. (OTCMKTS: ALYI) continues to see higher highs and higher lows...
DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology GenViroTM Anticipated to be Commercial Ready in Summer 2020...
DECN SETS PLAN TO MAKE UPCOMING PATENT INFRINGEMENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOVERY ++ COMPANY PLANS TO BUILD A FOUNDATION FOR...
DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN NEXT 7 DAYS, CLINICAL TRIALS TESTING TO BEGIN IN MAY ++ EQUITY FUND IN STEALTHY MOVE TRIED TO GAIN...
DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE GOVERNMENT SHUTDOWN ++ COMPANY ALSO REACHES PRICING...
++ COMPANY HAS ALSO AGREED TO MANUFACTURE A HOUSE BRAND PRODUCT FOR A “BIG BOX” AND WILL PROVIDE A FORECAST AND PRICE TERMS ONCE WE AGREE IN COMING DAYS ++ LOS...
DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court) ++ COMPANIES ANTICIPATE ANOTHER PRECEDENTIAL RULING FROM THE...
++ COMPANY ALSO READIES IMMINENT APPEAL IN THE JOHNSON & JOHNSON PATENT INFRINGEMENT MATTER WITH THE U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT ++ Los Angeles, CA -- December 17, 2018...
DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATIONS ++ IP AND PRODUCTS STRATEGY IS PUT IN PLACE TO INCREASE...
++ DECN TO LAUNCH GENCHOICE! PRODUCT IN SELECT INTERNATIONAL MARKETS JANUARY 2, 2019 AND TO FILE FOR CE MARK IN THE EU AND HEALTH CANADA APPROVAL IN EARLY 2019 ++ Los Angeles, CA -- December 4...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 11764 | 1.0E-6 | CS |
4 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 140815 | 1.0E-6 | CS |
12 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 99234 | 1.0E-6 | CS |
26 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 91196 | 1.0E-6 | CS |
52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 94414 | 1.0E-6 | CS |
156 | -0.0025 | -96.1538461538 | 0.0026 | 0.0027 | 1.0E-6 | 116074 | 0.00049994 | CS |
260 | -0.0186 | -99.4652406417 | 0.0187 | 0.497 | 1.0E-6 | 1999525 | 0.16282879 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales